LPL Financial
RYTM icon

LPL Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

LPL Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$698K Buy
6,284
+86
+1% +$7.78K ﹤0.01% 4747
2026
Q1 		$539K Buy
6,198
+771
+14% +$75K ﹤0.01% 4698
2025
Q4 		$581K Buy
5,427
+1,437
+36% +$152K ﹤0.01% 4586
2025
Q3 		$403K Sell
3,990
-815
-17% -$75.7K ﹤0.01% 4806
2025
Q2 		$304K Buy
4,805
+591
+14% +$36.2K ﹤0.01% 4764
2025
Q1 		$223K Buy
4,214
+39
+0.9% +$2.16K ﹤0.01% 4786
2024
Q4 		$234K Sell
4,175
-4,323
-51% -$239K ﹤0.01% 4718
2024
Q3 		$445K Buy
8,498
+1,620
+24% +$77.6K ﹤0.01% 4099
2024
Q2 		$282K Buy
6,878
+71
+1% +$2.83K ﹤0.01% 4321
2024
Q1 		$295K Sell
6,807
-50
-0.7% -$2.19K ﹤0.01% 4216
2023
Q4 		$315K Buy
+6,857
New +$216K ﹤0.01% 4050

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPL Financial's RYTM Position: Q2 2026 in Review

LPL Financial increased its Rhythm Pharmaceuticals (RYTM) stake by 1.4% in Q2 2026, buying an estimated $7.78K and bringing the position to 6,284 shares worth $698K. The position accounts for ﹤0.01% of the portfolio, ranked #4747.

LPL Financial first reported a position in RYTM in Q4 2023 and has held it in 11 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • LPL Financial held 6,284 shares of Rhythm Pharmaceuticals worth $698K as of Q2 2026.
  • LPL Financial bought 86 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $7.78K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4747 holding.
  • LPL Financial first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.